Palabras claves: Cardiovascular disease, Coronary artery disease, Hormone replacement therapy, lipoprotein(a), myocardial infarction, Physical activity, risk factor
Autores: Amell A., Añez-Ramos R., Arias F.B., Arráiz N., Cabrera M., Cano-Ponce C., Cruz S., González M.C., Mejías J.C., Mengual-Moreno E., Nava A., Rojas-Quintero J., Silva C., Sorell G L., Souki-Rincón A., Toledo A.C., Torres W., Torres Y., Valmore Bermúdez